SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001437749-22-022736
Filing Date
2022-09-19
Accepted
2022-09-19 17:21:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G teh20220919_sc13g.htm SC 13G 47366
  Complete submission text file 0001437749-22-022736.txt   48671
Mailing Address 1815 N. HALSTED CHICAGO IL 60614
Business Address
Hutchinson Thomas (Filed by) CIK: 0001612013 (see all company filings)

Type: SC 13G

Mailing Address 105 BRADFORD RD, SUITE 420 WEXFORD PA 15090
Business Address 105 BRADFORD RD, SUITE 420 WEXFORD PA 15090 724-934-6467
Coeptis Therapeutics Inc. (Subject) CIK: 0001819663 (see all company filings)

IRS No.: 843998117 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92267 | Film No.: 221251371
SIC: 2834 Pharmaceutical Preparations